Regulations/FDA QMSR/Evidence Readiness
Evidence Readiness · FDA QMSR

Evidence Readiness for FDA QMSR.

This page converts regulatory reading into evidence-readiness. It defines the records, owners, review questions, and trace fields that make a future checklist or readiness review defensible.

Source basis: Quality Management System Regulation amendments to 21 CFR Part 820Use: evidence-readinessBoundary: not legal advice
FDA QMSR TRACE 21 CFR PART 820 SCQMSR FINAL RULE ISO 13485:2016 IFDA-SPECIFIC PRO
/ Evidence objects

Readiness becomes visible through records.

FDA QMSR
Evidence 01

QMSR transition plan

Keep this as a named evidence object for FDA QMSR: source basis, owner, status, review question, and update trigger should be visible before reuse.

Evidence 02

ISO 13485 gap assessment

Keep this as a named evidence object for FDA QMSR: source basis, owner, status, review question, and update trigger should be visible before reuse.

Evidence 03

Procedure update register

Keep this as a named evidence object for FDA QMSR: source basis, owner, status, review question, and update trigger should be visible before reuse.

Evidence 04

Training completion record

Keep this as a named evidence object for FDA QMSR: source basis, owner, status, review question, and update trigger should be visible before reuse.

Evidence 05

Design control evidence index

Keep this as a named evidence object for FDA QMSR: source basis, owner, status, review question, and update trigger should be visible before reuse.

Evidence 06

Risk management file crosswalk

Keep this as a named evidence object for FDA QMSR: source basis, owner, status, review question, and update trigger should be visible before reuse.

Evidence 07

Supplier-control evidence map

Keep this as a named evidence object for FDA QMSR: source basis, owner, status, review question, and update trigger should be visible before reuse.

Evidence 08

CAPA effectiveness record

Keep this as a named evidence object for FDA QMSR: source basis, owner, status, review question, and update trigger should be visible before reuse.

Evidence 09

Management review evidence

Keep this as a named evidence object for FDA QMSR: source basis, owner, status, review question, and update trigger should be visible before reuse.

Evidence 10

Inspection readiness checklist

Keep this as a named evidence object for FDA QMSR: source basis, owner, status, review question, and update trigger should be visible before reuse.

/ Readiness questions

Each object needs review before reuse.

question bank
Question 01

QMSR transition plan

Ask: who owns it, what source does it trace to, what evidence exists, what is missing, and what should not be claimed?

Question 02

ISO 13485 gap assessment

Ask: who owns it, what source does it trace to, what evidence exists, what is missing, and what should not be claimed?

Question 03

Procedure update register

Ask: who owns it, what source does it trace to, what evidence exists, what is missing, and what should not be claimed?

Question 04

Training completion record

Ask: who owns it, what source does it trace to, what evidence exists, what is missing, and what should not be claimed?

Question 05

Design control evidence index

Ask: who owns it, what source does it trace to, what evidence exists, what is missing, and what should not be claimed?

Question 06

Risk management file crosswalk

Ask: who owns it, what source does it trace to, what evidence exists, what is missing, and what should not be claimed?

Question 07

Supplier-control evidence map

Ask: who owns it, what source does it trace to, what evidence exists, what is missing, and what should not be claimed?

Question 08

CAPA effectiveness record

Ask: who owns it, what source does it trace to, what evidence exists, what is missing, and what should not be claimed?